drugset / Trial / NCT04518176

Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins

NCT04518176

Unknown 400 enrolled Aswan University Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Objective to assess the effectiveness of prophylactic bilateral uterine artery ligation (BUAL) in reducing the incidence of postpartum hemorrhage during cesarean delivery among women with twin pregnancy

Timeline

Start
2020-09-01
Primary completion
2022-06-30
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Background Oxytocin Peptide 20 iu Intravenous

Indications

No indication recorded.